This report on tuberculosis testing studies the current as well as future prospects of the market globally. Tuberculosis (TB) is a highly contagious disease, and is caused due to Mycobacterium tuberculosis or MTB infection and majorly infects human lungs. People majorly suffer from two forms of TB: active tuberculosis and latent tuberculosis. The several types of TB based on the site of infection are pulmonary TB (lungs), skeletal TB (bone and joints), pleural TB, lymph node TB, gastrointestinal TB, and TB meningitis. Pulmonary TB is the most contagious disease and affects a large number of individuals globally. Based on types of tests, the tuberculosis testing market has been segmented into seven major categories: smear microscopy, culture-based tests, nucleic acid testing, Mantoux test or tuberculin skin tests (TST), radiography (chest x-ray), drug susceptibility testing (DST) and other TB tests.
This report comprises an elaborate executive summary that includes a market snapshot that provides overall information of various segments and sub-segments included in the study scope. This section also provides overall information and data analysis of the global tuberculosis testing market with respect to leading market segments based on types of tests as well as different geographic regions. The respective markets for the considered tuberculosis tests have been extensively analyzed on the basis of their usefulness, effectiveness, sales revenue and geographic presence. The market size and forecast in terms of USD million for each type of test has been provided for the period from 2012 to 2020. This report on tuberculosis testing market also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2014 to 2020, considering 2013 as the base year.
Geographically, the global tuberculosis testing market has been categorized into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). The market size and forecast for each of these regions have been provided for the period from 2012 to 2020, along with CAGR (%) for the forecast period from 2014 to 2020. The four major geographic markets have been further divided into seven sub-segments (major TB tests). The market size and forecast for each of these sub-segments have been provided for the period from 2012 to 2020, along with CAGR (%) for the forecast period from 2014 to 2020. The study also incorporates the competitive scenario in these regions.
A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global tuberculosis testing market and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis and Porter’s five forces analysis and key players’ market share and product wise heat map analysis in 2013 for the global TB testing market.
A list of recommendations has been provided for new entrants as well as existing market players to help establish a strong presence in the market and increase their market share. The report also profiles major players in the tuberculosis testing market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players profiled in this report include Abbott Laboratories, Akonni Biosystems, Inc., Alere, Inc., Becton, Dickinson and Company, bioMérieux SA, Cepheid, Epistem plc, F. Hoffmann-La Roche Ltd., Hain Lifescience GmbH, Hologic, QIAGEN, Sanofi and Thermo Fisher Scientific, Inc.
The global tuberculosis testing market is segmented as follows:
Tuberculosis Testing Market, by Test Type
- Smear Microscopy
- Culture Based Tests
- Nucleic Acid Testing
- Mantoux Test (Tuberculin Skin Test)
- Radiography (Chest X-Ray)
- Drug Susceptibility Testing (DST)
- Other Tests (Serological Tests, IGRA, ADA, etc.)
Tuberculosis Testing Market, by Geography
- North America
- Rest of the World (RoW)